What, me worry?

  • December 4, 2012
  • Comments off

bh IN BRIEF   An influenza pandemic will most likely hit Canada quickly and wreak havoc. Very few businesses have written a pandemic plan despite the likelihood of both high risk and high impacts: • Absence rates between 15% and 35%.• Serious and prolonged effects on supply lines and customer spending.• Overwhelmed government, health care, […]

Read More

The Question of Incentive

  • December 4, 2012
  • Comments off

bh IN BRIEF   The number of employers with workplace health programs and services is still less than 50%. Financial incentives might encourage more employers to get on board, either through the tax system, or through Workers’ Compensation (see The Bottom Line this issue). There is some $14 billion spent by employers each year on […]

Read More

The Mind of the Consumer

  • December 4, 2012
  • Comments off

bh IN BRIEF   It would be great to know "two-thirds of everything", as David Foot wrote in his 1990s best-selling book. Alas, there is very little hard information available to guide plan sponsors in their interactions and decisions related to benefit plans and member needs. The best advice is simply to ask, and to […]

Read More

Testing the Waters – A National Pool for High-Cost Drug Claims

  • December 4, 2012
  • Comments off

bh IN BRIEF   Employers are challenged by high-cost individual drug claims, especially by ‘new and improved’ (and costly) biologic products. Insurer claim pooling is inexpensive, but many employers don’t buy it, or believe it provides only limited protection after they incur a large claim. Ever-escalating claims are driving smaller employers to reduce or eliminate […]

Read More

Patient Safety – Are Canadian Hospitals “Taking Care of Business”?

  • December 4, 2012
  • Comments off

bh IN BRIEF   Patient safety costs all Canadians, dearly. This includes employers because medical errors keep people away from work through extended hospital stays, disabilities, and, too often, premature death.Recently, the first Canadian study estimated 7.5% of those hospitalized suffer an adverse event, and that almost 40% of those were avoidable. Between 9,000 and […]

Read More

Pushing Drug Plans

  • November 16, 2012
  • Comments off

  bh IN BRIEF   A slate of singular though important changes affecting drug plans has occurred across Canada in recent months. Three older brand-name drugs have replaced their formerly low-cost generic competitors in both public and private plans. The BC and Ontario governments are making their own deals with brand-name manufacturers. And pharmacists are […]

Read More